Bridget Brisk

Genesis Biotechnology Group

The Genesis Biotechnology Group is a consortium of vertically integrated corporate entities, which facilitate the overall market implementation and delivery of basic science products such as diagnostic assays and drug discovery. Through the consolidation of research activities in the fields of biotechnology, molecular biology, genome research, biochemistry, nano and biophysics, bioinformatics, and computer science, we are able to cultivate research partnerships between highly productive research teams that break through the barriers of traditional disciplinary boundaries. Our mission is to improve the patient's quality of life through the cross-linking of basic science research and implementation in the clinical laboratory.